These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3818014)

  • 41. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pressor mechanisms of vasopressin in DOC-salt hypertensive rats--interaction with autonomic nervous system.
    Matsuguchi H; Schmid PG
    Jpn Circ J; 1982 May; 46(5):531-3. PubMed ID: 7077815
    [No Abstract]   [Full Text] [Related]  

  • 43. Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension.
    Filep J; Frölich JC; Fejes-Toth G
    Clin Exp Hypertens A; 1985; 7(10):1457-70. PubMed ID: 3841034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.
    Trinder D; Phillips PA; Risvanis J; Stephenson JM; Johnston CI
    Hypertension; 1992 Oct; 20(4):569-74. PubMed ID: 1398892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasopressin and malignant deoxycorticosterone hypertension in rats.
    Möhring J; Möhring B; Petri M; Haack D
    Clin Sci Mol Med Suppl; 1976 Dec; 3():45s-48s. PubMed ID: 1071663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats.
    Arvola P; Ruskoaho H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 19-nor-deoxycorticosterone excretion in rats bred for susceptibility and resistance to the hypertensive effects of salt.
    Dale SL; Holbrook MM; Melby JC
    Endocrinology; 1985 Dec; 117(6):2424-7. PubMed ID: 4065039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of chloride in deoxycorticosterone hypertension: selective sodium loading by diet or drinking fluid.
    Kunes J; Zicha J; Jelínek J
    Physiol Res; 2004; 53(2):149-54. PubMed ID: 15046550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary tritium excretion following intravenous 3H-norepinephrine administration in hypertensive rats.
    Gitlow S; Wong B; Dziedzic L; Dziedzic S
    Clin Exp Hypertens (1978); 1980 Feb; 2(2):169-82. PubMed ID: 7418543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin.
    Intengan HD; Park JB; Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):907-13. PubMed ID: 10523383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Responsiveness of locus ceruleus neurons in hypertensive rats to vasopressin.
    Berecek KH; Olpe HR; Hofbauer KG
    Hypertension; 1987 Jun; 9(6 Pt 2):III110-3. PubMed ID: 3596777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidences against a primary role for the pituitary neural lobe in the development and maintenance of DOC-salt hypertension.
    Cannata MA; Taquini AC
    Acta Physiol Pharmacol Latinoam; 1987; 37(2):207-14. PubMed ID: 3425339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension.
    Möhring J; Möhring B; Petri M; Haack D
    Am J Physiol; 1977 Mar; 232(3):F260-9. PubMed ID: 842673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal nerves are not necessary for onset or maintenance of DOC-salt hypertension in rats.
    Dzielak DJ; Norman RA
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H945-9. PubMed ID: 4061671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasopressin as a possible contributor to hypertension.
    Yazaki Y; Ohuchi Y; Ashida T; Tsai R; Yoshizumi M
    Jpn Circ J; 1984 Feb; 48(2):188-95. PubMed ID: 6321816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic kinin receptor blockade induces hypertension in deoxycorticosterone-treated rats.
    Madeddu P; Anania V; Parpaglia PP; Demontis MP; Varoni MV; Fattaccio MC; Glorioso N
    Br J Pharmacol; 1993 Mar; 108(3):651-7. PubMed ID: 8385532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.